BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17081079)

  • 1. Kidney disease and cardiovascular risk.
    Tonelli M; Pfeffer MA
    Annu Rev Med; 2007; 58():123-39. PubMed ID: 17081079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk and management in chronic kidney disease.
    Rucker D; Tonelli M
    Nat Rev Nephrol; 2009 May; 5(5):287-96. PubMed ID: 19384330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.
    Tomey MI; Winston JA
    Ann Glob Health; 2014; 80(1):69-76. PubMed ID: 24751567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.
    Ardhanari S; Alpert MA; Aggarwal K
    Adv Perit Dial; 2014; 30():40-53. PubMed ID: 25338421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease 10 years on: what have we learned?
    Taal MW
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):607-11. PubMed ID: 23010759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension in moderate-to-severe nondiabetic CKD patients.
    Segura J; Ruilope LM
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):23-7. PubMed ID: 21224027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors.
    Sera N; Hida A; Imaizumi M; Nakashima E; Akahoshi M
    Radiat Res; 2013 Jan; 179(1):46-52. PubMed ID: 23148507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease, diabetes mellitus and cardiovascular disease: risks and commonalities.
    Suckling R; Gallagher H
    J Ren Care; 2012 Feb; 38 Suppl 1():4-11. PubMed ID: 22348359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
    Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
    J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for cardiovascular system damage in chronic kidney disease].
    Kutyrina IM; Rudenko TE; Savel'eva SA; Shvetsov MIu; Vasil'eva MP
    Ter Arkh; 2013; 85(9):69-76. PubMed ID: 24261233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-renal syndrome type 4: epidemiology, pathophysiology and treatment.
    House AA
    Semin Nephrol; 2012 Jan; 32(1):40-8. PubMed ID: 22365161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological benefits of exercise in pre-dialysis chronic kidney disease.
    Gould DW; Graham-Brown MP; Watson EL; Viana JL; Smith AC
    Nephrology (Carlton); 2014 Sep; 19(9):519-27. PubMed ID: 24899042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients.
    Fernandez-Fresnedo G; Rodrigo E; de Francisco AL; de Castro SS; Castañeda O; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S246-9. PubMed ID: 17130269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular system in patients in different stages of chronic kidney disease].
    Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
    Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.
    De Serres SA; Varghese JC; Levin A
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):619-27. PubMed ID: 22914685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine alterations and cardiovascular risk in CKD: is there a link?
    Ros S; Carrero JJ
    Nefrologia; 2013; 33(2):181-7. PubMed ID: 23511754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in chronic kidney disease: untying the Gordian knot.
    Hajhosseiny R; Khavandi K; Goldsmith DJ
    Int J Clin Pract; 2013 Jan; 67(1):14-31. PubMed ID: 22780692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
    Staude H; Jeske S; Schmitz K; Warncke G; Fischer DC
    Kidney Blood Press Res; 2013; 37(1):68-83. PubMed ID: 23548827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.